Flagship Pioneering Inc.
13F Portfolio Filings
- Most recent 13FQ4 2024
- Locationcambridge, MA
- CIK0001400240
- Alternate namesFlagship Ventures Management, Inc.
- All SEC filings
Quater | Holdings | VALUE | Top Holdings | Form Type | Date Filed | Filing Id | |
|---|---|---|---|---|---|---|---|
5 | $334.22M | MRNA, FHTX, SANA, OMGA | 13F-HR | Feb 14, 2025 | 000095012325002708 | ||
6 | $591.88M | MRNA, FHTX, SANA, OMGA | 13F-HR | Nov 14, 2024 | 000095012324011756 | ||
6 | $843.36M | MRNA, SANA, FHTX, OMGA | 13F-HR | Aug 14, 2024 | 000095012324008727 | ||
7 | $1.52B | MRNA, SANA, OMGA, FHTX | 13F-HR | May 15, 2024 | 000095012324005589 | ||
7 | $1.33B | MRNA, SANA, OMGA, FHTX | 13F-HR | Feb 14, 2024 | 000095012324002510 | ||
9 | $1.38B | MRNA, SANA, FHTX, OMGA | 13F-HR | Nov 14, 2023 | 000095012323010821 | ||
10 | $2.24B | MRNA, SANA, OMGA, MCRB | 13F-HR | Aug 14, 2023 | 000095012323008070 | ||
11 | $2.57B | MRNA, OMGA, MCRB, SANA | 13F-HR | May 15, 2023 | 000095012323005258 | ||
12 | $3.13B | MRNA, OMGA, SANA, MCRB | 13F-HR | Feb 14, 2023 | 000095012323002460 | ||
12 | $2.38B | MRNA, SANA, MCRB, OMGA | 13F-HR | Nov 14, 2022 | 000095012322012261 | ||
12 | $2.65B | MRNA, SANA, FHTX, EVLO | 13F-HR | Aug 15, 2022 | 000095012322009421 | ||
13 | $4.26B | MRNA, SANA, RUBIUS THERAPEUTICS INC, FHTX | 13F-HR | May 16, 2022 | 000095012322006309 | ||
13 | $6.47B | MRNA, SANA, RUBIUS THERAPEUTICS INC, OMGA | 13F-HR | Feb 14, 2022 | 000095012322002901 | ||
13 | $9.55B | MRNA, SANA, RUBIUS THERAPEUTICS INC, OMGA | 13F-HR | Nov 15, 2021 | 000095012321015487 | ||
12 | $7.83B | MRNA, RUBIUS THERAPEUTICS INC, SANA, MCRB | 13F-HR | Aug 16, 2021 | 000095012321011113 | ||
12 | $6.24B | MRNA, SANA, RUBIUS THERAPEUTICS INC, MCRB | 13F-HR | May 17, 2021 | 000095012321007079 | ||
11 | $5.49B | MRNA, SGTX, MCRB, RUBIUS THERAPEUTICS INC | 13F-HR | Feb 16, 2021 | 000095012321002948 | ||
8 | $3.62B | MRNA, MCRB, KLDO, DNLI | 13F-HR | Nov 16, 2020 | 000095012320012128 | ||
8 | $3.44B | MRNA, RUBIUS THERAPEUTICS INC, DNLI, KLDO | 13F-HR | Aug 13, 2020 | 000095012320008652 | ||
8 | $2.13B | MRNA, RUBIUS THERAPEUTICS INC, DNLI, KLDO | 13F-HR | May 14, 2020 | 000095012320004927 | ||
9 | $1.79B | MRNA, RUBIUS THERAPEUTICS INC, DNLI, KLDO | 13F-HR | Feb 13, 2020 | 000095012320001884 | ||
10 | $1.83B | MRNA, RUBIUS THERAPEUTICS INC, KLDO, DNLI | 13F-HR | Nov 14, 2019 | 000095012319011393 | ||
10 | $2.31B | MRNA, RUBIUS THERAPEUTICS INC, KLDO, DNLI | 13F-HR | Aug 13, 2019 | 000095012319007818 | ||
8 | $2.64B | MRNA, RUBIUS THERAPEUTICS INC, KLDO, DNLI | 13F-HR | May 14, 2019 | 000101297519000346 | ||
7 | $2.05B | MRNA, RUBIUS THERAPEUTICS INC, EVLO, DNLI | 13F-HR | Feb 13, 2019 | 000101297519000145 | ||
6 | $1.51B | RUBIUS THERAPEUTICS INC, EVLO, DNLI, MCRB | 13F-HR | Nov 13, 2018 | 000101297518001201 | ||
5 | $522.11M | EVLO, DNLI, MCRB, SYRS | 13F-HR | Aug 7, 2018 | 000101297518000952 | ||
4 | $344.90M | DNLI, MCRB, SYRS, QTRX | 13F-HR | May 15, 2018 | 000101297518000415 | ||
5 | $394.32M | DNLI, MCRB, EDIT, QTRX | 13F-HR | Feb 14, 2018 | 000101297518000160 | ||
4 | $299.00M | MCRB, SYRS, EDIT, TTOOEUR | 13F-HR | Nov 3, 2017 | 000101297517000806 | ||
4 | $283.57M | MCRB, SYRS, EDIT, TTOOEUR | 13F-HR | Aug 2, 2017 | 000101297517000578 | ||
7 | $376.25M | MCRB, SYRS, EDIT, AGIO | 13F-HR | May 10, 2017 | 000101297517000377 | ||
7 | $307.34M | MCRB, SYRS, EDIT, AGIO | 13F-HR | Feb 13, 2017 | 000101297517000113 | ||
7 | $366.00M | MCRB, SYRS, AGIO, EDIT | 13F-HR | Nov 14, 2016 | 000101297516001561 |